Return On Assets of Spero Therapeutics, Inc. from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Spero Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • Spero Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -58%, a 2691% decline year-over-year.
  • Spero Therapeutics, Inc. annual Return On Assets for 2024 was -49%, a 367% decline from 2023.
  • Spero Therapeutics, Inc. annual Return On Assets for 2023 was 18%.
  • Spero Therapeutics, Inc. annual Return On Assets for 2021 was -62%, a 2.6% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Spero Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -58% -60% -2691% 01 Jul 2025 30 Sep 2025
Q2 2025 -56% -67% -583% 01 Apr 2025 30 Jun 2025
Q1 2025 -59% -76% -450% 01 Jan 2025 31 Mar 2025
Q4 2024 -49% -67% -367% 01 Oct 2024 31 Dec 2024
Q3 2024 2% 01 Jul 2024 30 Sep 2024
Q2 2024 12% 01 Apr 2024 30 Jun 2024
Q1 2024 17% 01 Jan 2024 31 Mar 2024
Q4 2023 18% 01 Oct 2023 31 Dec 2023
Q3 2022 -92% -36% -63% 01 Jul 2022 30 Sep 2022
Q2 2022 -86% -34% -64% 01 Apr 2022 30 Jun 2022
Q1 2022 -71% -17% -32% 01 Jan 2022 31 Mar 2022
Q4 2021 -62% -2% -2.6% 01 Oct 2021 31 Dec 2021
Q3 2021 -56% +16% +22% 01 Jul 2021 30 Sep 2021
Q2 2021 -53% +26% +33% 01 Apr 2021 30 Jun 2021
Q1 2021 -54% +16% +23% 01 Jan 2021 31 Mar 2021
Q4 2020 -60% -8% -16% 01 Oct 2020 31 Dec 2020
Q3 2020 -72% -34% -88% 01 Jul 2020 30 Sep 2020
Q2 2020 -78% -48% -154% 01 Apr 2020 30 Jun 2020
Q1 2020 -70% -39% -124% 01 Jan 2020 31 Mar 2020
Q4 2019 -52% -12% -31% 01 Oct 2019 31 Dec 2019
Q3 2019 -38% +9% +19% 01 Jul 2019 30 Sep 2019
Q2 2019 -31% +33% +52% 01 Apr 2019 30 Jun 2019
Q1 2019 -31% 01 Jan 2019 31 Mar 2019
Q4 2018 -40% 01 Oct 2018 31 Dec 2018
Q3 2018 -47% 01 Jul 2018 30 Sep 2018
Q2 2018 -64% 01 Apr 2018 30 Jun 2018

Spero Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -49% -67% -367% 01 Jan 2024 31 Dec 2024
2023 18% 01 Jan 2023 31 Dec 2023
2021 -62% -2% -2.6% 01 Jan 2021 31 Dec 2021
2020 -60% -8% -16% 01 Jan 2020 31 Dec 2020
2019 -52% -12% -31% 01 Jan 2019 31 Dec 2019
2018 -40% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.